2020 Final Resolution: Day 1

Finalized Resolution

IOWA HIGH SCHOOL MODEL UNITED NATIONS

IOWA YOUTH SYMPOSIUM

Resolution (2020)

Adopted on: Tuesday, October 20th at 2:10 PM

Resolution created by the Science Committee

Regarding: Vaccine Development and Distribution

Preambulatory Clauses:

RECOGNIZING a vaccine is a type of medicine that is injected into someone to build immunity to a virus, bacteria, or disease, and

ACKNOWLEDGING that the World Health Organization has taken action to promote vaccinations on most accounts in the past, and

BEARING IN MIND Vaccines don't always prevent virus but help lower symptoms, and

ACKNOWLEDGING the devastating effect lack of funds can produce on the development of vaccines and stopping the spread of viruses, and

BEARING IN MIND that vaccination, as supported by the WHO and partners, has reduced Polio by 99 percent, and

ACKNOWLEDGING the recovery rate of Covid-19, and

EXPRESSING appreciation for the professionals working on vaccines, and

NOTING WITH DEEP CONCERN that some countries are risking the safety of their people and the safety of the vaccines themselves to try and fast track them, and

Aware that the FDA has approved fast-tracking for certain COVID-19 vaccines, and

RECOGNIZING medical companies have received funding for vaccine development, and

RECOGNIZING vaccine development usually has several different stages, the exploratory stage, pre-clinical stage, clinical development, regulatory review and approval, manufacturing, and quality control, and

ACKNOWLEDGING in 1974 the World Health Organization (WHO) established the Expanded Program on Immunization (EPI). This program included routine infant immunizations for tuberculosis, poliomyelitis, diphtheria, tetanus, pertussis, and measles, and

AWARE OF the speed Covid-19 vaccines are being developed, and

AFFIRMING it is crucial to execute enough clinical testing on a vaccine in order to ensure the saftey of the population receiving the vaccine, and

COGNIZANT THAT competition between pharmaceutical companies may create irresponsible haste in vaccine development, and

ACKNOWLEDGING that vaccines are often required to be held at very low temperatures with little tolerance, and

FULLY AWARE that the US federal government has donated over $9 Billion USD to 7 companies for vaccine development and research, and

ACKNOWLEDGING The importance of vaccines for public safety and extending life expectancy, and

AWARE OF the negative effects not having access to vaccines has on communities and the human population, and

AWARE OF the substantial amount of developed vaccines that have had to be disposed of because they were not kept at the appropriate temperatures, and

MINDFUL OF the importance of the chain of supply and the demands of cold temperatures, glass holding vials, and syringes, and

COGNIZANT OF the large cost of vaccines and the money that must go into producing them, and

Actuating Clauses:

CALLS UPON the United Nations to allocate funds from budget to create a monetary safety net that supports vaccine development done by accredited institutions and further funds efforts to secure the chain of supply for developing countries, and

ENCOURAGES low pricing on vaccines in order to ensure companies are developing vaccines for the better good rather than financial gain, and

EMPHASIZES the importance for nations to continue work on distributing vaccines to needed areas quickly and effectively, and

RECOMMENDS that groups such as the WHO and the ICG continue to receive support from the UN, and

ENCOURAGES the world health community to consider nations' ability to properly handle and distribute vaccines when determining which nations receive early vaccines, and

RECOMMENDS placing UN organizations such as the WHO and COVAX in charge of vaccine distribution, and

ENCOURAGES countries to distribute vaccines to medical workers, elderly, and people with underlying health conditions first when Covid-19 vaccine becomes approved by FDA and CDC, and

CALLS UPON member nations and vaccine developers to prioritize safety and precaution over haste in vaccine development and testing, and